GlassScriptPhysician profile
Rhorie Kerr
NPI 1881013852
$4,759.94
in general payments reported to CMS, 2019-2025
13 companies · $622 in 2025
The $622 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $419 · 2021: $511 · 2022: $350 · 2023: $783 · 2024: $1,692 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,087 · Travel and Lodging: $1,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,087.31 |
| Travel and Lodging | $1,008.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,072.76 | 2019-2025 | Na, Vsp System, Vsp Cranial, Medpor Titan |
| Allergan, INC. | $415.26 | 2019-2021 | |
| Integra Lifesciences Corporation | $320.90 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $146.97 | 2024 | Novosorb Btm |
| Smith+Nephew, INC. | $146.67 | 2024 | Ent Sinus |
| Merz Pharmaceuticals, LLC | $142.68 | 2024 | Xeomin |
| Medtronic, INC. | $119.14 | 2025 | Nuvent, Fusion |
| Abbvie INC. | $113.40 | 2022 | |
| Axogen | $89.28 | 2023 | Avance Nerve Graft |
| Coopersurgical, INC. | $72.23 | 2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Karl Storz Endoscopy-America | $54.88 | 2025 | |
| Acera Surgical, INC. | $39.54 | 2025 | Restrata Wound Matrix |
| Ethicon US, LLC | $26.23 | 2023 | Dermabond Prineo, Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhorie Kerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.